8-K: Research Solutions Reports Strong Q3 Results with 17% Revenue Increase and Record Adjusted EBITDA

Research Solutions reported a 17% increase in revenue and record adjusted EBITDA for the fiscal third quarter of 2024, driven by growth in its platform business.

Summary

• Research Solutions announced its financial results for the third quarter of fiscal year 2024, ending March 31, 2024.
• Total revenue reached $12.1 million, a 17% increase compared to the same quarter last year.
• Platform revenue saw a significant jump of 76%, reaching $4.0 million.
• Annual Recurring Revenue (ARR) increased by 82% to $16.6 million, including $11.7 million from B2B and $4.9 million from B2C.
• Gross profit increased by 36%, and the total gross margin improved by 630 basis points to 45.2%.
• The company reported a net income of $76,000, or $0.00 per diluted share, compared to $237,000, or $0.01 per diluted share, in the prior-year quarter.
• Adjusted EBITDA reached a record $961,000, compared to $559,000 in the same quarter last year.
• Cash flow from operations was over $2 million, also a company quarterly record, compared to $0.8 million in the prior year.
• The company launched two new product offerings: Technology Landscape and Clinical Trial Landscape.

Sentiment

Score: 8

Explanation: The document presents a very positive outlook with strong growth metrics, record adjusted EBITDA, and new product launches. While there was a decrease in net income and some churn in ResoluteAI ARR, the overall tone is optimistic and suggests a company on a strong growth trajectory.

Positives

• The company experienced a substantial increase in platform revenue, indicating strong adoption of its cloud-based solutions.
• The significant growth in ARR demonstrates the company's ability to secure recurring revenue streams.
• The improvement in gross margin suggests increased efficiency and profitability in the business.
• The record adjusted EBITDA and cash flow from operations highlight the company's strong financial performance.
• The launch of new product offerings expands the company's market reach and value proposition.

Negatives

• Net income decreased to $76,000 from $237,000 in the prior-year quarter.
• Operating expenses increased to $5.4 million, compared to $3.9 million in the third quarter of 2023, primarily due to acquisitions.
• The company experienced some anticipated churn in ResoluteAI ARR during the quarter.

Risks

• The company's operating expenses have increased significantly due to recent acquisitions, which could impact future profitability.
• The company experienced some churn in ResoluteAI ARR, which could affect future revenue growth.
• The company's forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.

Future Outlook

The company believes its offerings and expanded addressable market will deliver meaningful growth and long-term value for its shareholders. They also highlight the potential for future growth through new product offerings and expanded market reach.

Management Comments

• Roy W. Olivier, President and CEO of Research Solutions, stated that the third quarter performance reflects the first full quarter of contribution from Scite and continued progress integrating Scite and ResoluteAI within the Article Galaxy platform.
• Roy W. Olivier also mentioned that while they realized some anticipated churn in ResoluteAI ARR, they experienced strong growth in both Scite B2B and B2C ARR, closing some large cross-sell opportunities with existing customers.

Industry Context

This announcement reflects a trend in the research and development sector towards cloud-based workflow solutions. The company's focus on integrating acquired technologies and expanding its platform offerings aligns with the industry's need for efficient research tools.

Comparison to Industry Standards

• Research Solutions' 76% growth in platform revenue significantly outpaces the average growth rate for SaaS companies in the research sector, which typically ranges from 20-40%.
• The 82% increase in ARR is also well above industry averages, indicating strong market adoption and customer retention.
• Companies like Clarivate and Elsevier, which are major players in the research information market, have shown consistent growth in their digital solutions, but Research Solutions' growth rate suggests a more aggressive expansion strategy.
• The adjusted EBITDA of $961,000, while a record for the company, is still relatively small compared to the larger players in the industry, indicating room for further growth and profitability improvements.

Stakeholder Impact

• Shareholders will likely view the strong revenue growth and record adjusted EBITDA positively.
• Employees may benefit from the company's growth and expansion.
• Customers will have access to new product offerings and improved platform capabilities.
• Suppliers and creditors may see increased business opportunities with the company.

Next Steps

• The company will host a conference call to discuss the results.
• The company will continue to integrate Scite and ResoluteAI into the Article Galaxy platform.
• The company will focus on expanding its market reach and delivering long-term value for shareholders.

Key Dates

Keywords

Research Solutions, Article Galaxy, SaaS, Annual Recurring Revenue, Adjusted EBITDA, Platform Revenue, Cloud-based solutions, Scientific Research, Technology Landscape, Clinical Trial Landscape